Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-24-000016
Filing Date
2024-07-25
Accepted
2024-07-25 10:26:48
Documents
122
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K sny-20240630.htm   iXBRL 6-K 405862
2 EX-99.1 sny-20240630_d2.htm   iXBRL EX-99.1 1595000
3 EX-99.2 exhibit992-2024halfyearman.htm EX-99.2 660900
10 a1a.gif GRAPHIC 60991
11 a2a.gif GRAPHIC 56601
12 a3a.gif GRAPHIC 37577
13 cv3a.jpg GRAPHIC 48134
14 cvhy3a.jpg GRAPHIC 23636
  Complete submission text file 0001121404-24-000016.txt   13973768

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sny-20240630.xsd EX-101.SCH 161238
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sny-20240630_cal.xml EX-101.CAL 131702
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sny-20240630_def.xml EX-101.DEF 589031
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sny-20240630_lab.xml EX-101.LAB 1084700
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sny-20240630_pre.xml EX-101.PRE 797029
125 EXTRACTED XBRL INSTANCE DOCUMENT sny-20240630_htm.xml XML 2642778
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 241140327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)